Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial

Journal of Hepatology

Volumn 29, Issue 1, 1998, Pages 129-134

  Pelletier, Gilles ^a   Ducreux, Michel ^b   Gay, France ^c   Luboinski, Monique ^b   Hagège, Herve ^d   Thong, Dao ^e   Van Steenbergen, Werner ^f   Buffet, Catherine ^a   Rougier, Philippe ^b   Adler, Michael ^c   Pignon, Jean Pierre ^b   Roche, Alain ^b  

^a BICÊTRE HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c ERASME HOSPITAL   (Belgium)

^d CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^e CHU CÔTE DE NACRE   (France)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Liver neoplasms

Indexed keywords

CISPLATIN; GELATIN; IODINATED POPPYSEED OIL; PHOSPHATIDYLCHOLINE; TAMOXIFEN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 7144255522     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80187-6     Document Type: Article

References (19)

1. Groupe d'Étude et de Traitement du Carcinome Hépatocellulaire A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 332:1995;1256-1261.
2. Bronowicki JP, Boudjema K, Chone L, Nisand G, Bazin C, Pflumio F, et al. Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol. 24:1996;293-300.
3. Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol. 11:1990;181-184.
4. Kasugai H, Kojima J, Tatsuta M, Okuda S, Sasaki Y, Imaoka S, et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology. 97:1989;965-971.
5. Doppman JL, Dunnick NR, Girton M, Fauci AS, Popovsky MA. Bile duct cysts secondary to liver infarcts: report of a case and experimental production by small vessel hepatic artery occlusion. Radiology. 156:1985;331-334.
6. Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, et al. Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization. Radiology. 147:1983;401-405.
7. Farinati F, Salvagnini M, de Maria N, Fornasiero A, Chiaramonte M, Rossaro L, et al. Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen. J Hepatol. 11:1990;297-301.
8. Martinez Cerezo FJ, Tomas A, Donoso L, Enriquez J, Guarner C, Balanzo J, et al. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma. J Hepatol. 20:1994;702-706.
9. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 56:1985;918-8.
10. Castells A, Bruix J, Bru C, Ayuso C, Roca M, Boix L, et al. Treatment of hepatocellular carcinoma with tamoxifen: a double blind placebo-controlled trial in 120 patients. Gastroenterology. 109:1995;917-922.
11. Fukushima S, Kubota M, Kojima T, Nakano T, Shibata J, Fujiyama S, et al. Preparation and evaluation of two formulations: cisplatin suspension in lipiodol and polylactic acid microspheres containing aclarubicin hypochloride for hepatic arterial administration therapy for hepatocellular carcinoma. Reg Cancer Treat. 2:1992;36-39.
12. Zhao Z, Ramirez LH, Simenauer N. Intrahepatic arterial chemotherapy using piparubucin combined with lipiodol in rabbits bearing VH2 tumors. Reg Cancer Treat. 4:1993;213-217.
13. De Baere T, Dufaux J, Roche A, Counnord JL, Berthault MF, Denys A, et al. Circulatory alterations induced by intraarterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study. Radiology. 194:1995;165-170.
14. De Baere T, Zhang X, Aubert B, Harry G, Lagrange C, Ropers J, et al. Quantification of tumor uptake of iodized oils and emulsions: experimental study. Radiology. 201:1996;731-735.
15. Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, et al. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology. 19:1994;1115-1123.
16. Hatanaka Y, Yamashita Y, Koga Y, Saito R, Nakamshima K, Urata J, et al. Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology. 195:1995;747-752.
17. Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 163:1992;387-394.
18. Vetter D, Wenger JJ, Bergier JM, Doffoel M, Bockel R. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a Western comparative study in 60 patients. Hepatology. 13:1991;427-433.
19. Ryder SD, Rizzi PM, Metivier E, Karani J, Williams R. Chemoembolization with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma. Gut. 38:1996;125-128.